KALA BIO Inc. – Credit Agreements

NASDAQ: KALA
Share price (8/20/26): $0.84
Market cap (8/20/26): $16.2 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Credit Agreements Filter

from 8-K 7 pages Loan Settlement Agreement

from 10-Q 20 pages Convertible Loan Agreement

from 10-Q 7 pages Fifth Amendment to Loan and Security Agreement

from 10-Q 10 pages Fourth Amendment to Loan and Security Agreement

from 8-K 7 pages Third Amendment to Loan and Security Agreement

from 10-Q 7 pages Second Amendment to Loan and Security Agreement

from 8-K 42 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is the Type of Information That the Registrant Treats as Private or Confidential. Double Asterisks Denote Omissions. Loan and Security Agreement

from 8-K 169 pages Credit Agreement Dated as of October 1, 2018 Among Kala Pharmaceuticals, Inc., as the Borrower, Certain Subsidiaries of the Borrower, as the Guarantors, Athyrium Opportunities III Acquisition LP, as the Administrative Agent and the Lenders From Time to Time Party Hereto

from 10-K 96 pages Kala Pharmaceuticals, Inc. Loan and Security Agreement

from S-1 76 pages Kala Pharmaceuticals, Inc. Loan and Security Agreement

from DRS/A 76 pages Kala Pharmaceuticals, Inc. Loan and Security Agreement

from DRS 47 pages Kala Pharmaceuticals, Inc. Loan and Security Agreement